Post-approval studies (Phase 4)Study completedNCT02417649
What this trial is testing
Advanced Immunological Approach in COPD Exacerbation
Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Lallemand Pharma AG 288
Showing 20 of 0 results